0001179110-21-010095.txt : 20211112 0001179110-21-010095.hdr.sgml : 20211112 20211112161531 ACCESSION NUMBER: 0001179110-21-010095 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211109 FILED AS OF DATE: 20211112 DATE AS OF CHANGE: 20211112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Veness Adam M CENTRAL INDEX KEY: 0001778623 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36065 FILM NUMBER: 211403670 MAIL ADDRESS: STREET 1: C/O ACCELERON PHARMA INC. STREET 2: 128 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACCELERON PHARMA INC CENTRAL INDEX KEY: 0001280600 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 128 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-649-9200 MAIL ADDRESS: STREET 1: 128 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2021-11-09 0 0001280600 ACCELERON PHARMA INC XLRN 0001778623 Veness Adam M 128 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 SVP, General Counsel and Sec. Common Stock 2021-11-09 4 M 0 4500 29.37 A 23423 D Option to Purchase Common Stock 29.37 2021-11-09 4 M 0 4500 0 D 2024-08-01 Common Stock 4500 0 D The shares of common stock underlying this stock option award vested as to 25% of the shares on July 14, 2015 and the remaining shares vested in equal quarterly installments over the following three years thereafter. /s/ Adam M. Veness 2021-11-12